Reviva Pharmaceuticals Holdings Inc.

NASDAQ:RVPH  
3.65
+0.14 (+3.99%)
Earnings Announcements

Reviva Pharmaceuticals Holdings Reports Third Quarter 2021 Financial Results

Published: 11/15/2021 14:55 GMT
Reviva Pharmaceuticals Holdings Inc. (RVPH) - Reports Third Quarter 2021 Financial Results and Recent Business Highlights.
Q3 Loss per Share $0.12.
Cash and Cash Equivalents of Quarter Ended Sept 30, 2021 Expected to Cover General Operating Expenses Through Q4 of 2022.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.27

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.